Deese J, Pradhan S, Goetz H, Morrison C. Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives. Open Access Journal of Contraception 2018:9 91–112. https://doi.org/10.2147/OAJC.S135439.
Morrison C, Fichorova R, Chen PL, Kwok C, Deese J, Yamamoto H, Anderson S, Chipato T, Salata R, Doncel G. A Longitudinal Assessment of Cervical Inflammation and Immunity associated with HIV-1 Infection, Hormonal Contraception and Pregnancy. AIDS Res Hum Retroviruses. Oct 2018. Ahead of print https://doi.org/10.1089/AID.2018.0022.
Masson L, Barnabas S, Deese J, Lennard K, Dabee S, Gamieldien H, Jaumdally SZ, Williamson AL, Little F, Van Damme L, Ahmed K, Crucitti T, Abdellati S, Bekker LG, Gray G, Dietrich J, Jaspan H, Passmore JA. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicenter validation study. Sex Transm Infect. Jul 2018. Published online first https://doi.org/10.1136/sextrans-2017-053506.
Fransen K, de Baetselier I, Rammutla E, Ahmed K, Owino F, Agingu W, Venter G, Deese J, Van Damme L, Crucitti T. Performance of Serological and Molecular Tests within Acute HIV Infection. J Clin Virol. Aug 2017. Published online first http://dx.doi.org/10.1016/j.jcv.2017.03.010.
Fransen K, de Baetselier I, Rammutla E, Ahmed K, Owino F, Agingu W, Venter G, Deese J, Van Damme L, Crucitti T for the FEM-PrEP study group. Detection of New HIV Infections in a Multicentre HIV Antiretroviral Pre-exposure Prophylaxis Trial. J Clin Virol. Published online first Mar 2017 https://doi.org/10.1016/j.jcv.2017.03.013.
de Baetselier I, Taylor D, Mandala J, Nanda K, Van Dampenhout C, Agingu W, Madurai L, Barsch E, Deese J, Van Damme L, Crucitti T. Verification of Chemistry Reference Ranges using a Simple Method in Different Sub-Saharan African Settings during a Phase III Clinical Trial. Afr J Lab Med. Oct 2016. Published online first https://doi.org/10.4102/ajlm.v5i1.404.
Mookho M, Ahmed K, Deese J, Nanda K, Van Damme L, De Baetselier I, Burnett J. Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: A Case Report. J Med Case Rep. 2015 Sep 28; 9: 207. https://doi.org/10.1186/s13256-015-0679-4.
Deese J, Masson L, Miller W, Cohen M, Morrison C, Wang M, Ahmed K, Agot K, Crucitti T, Abdellati S, Van Damme L. Injectable progestin-only contraception is associated with increased levels of pro-inflammatory cytokines in the female genital tract. Am J Reprod Immunol. Jul 2015. Published online first https://doi.org/10.1111/aji.12415.
De Baetselier I, Cuylaerts V, Rammutla E, Ahmed K, Deese J, Van Damme L, Menten J, Crucitti T for the FEM-PrEP Study Group. Prevalence and Incidence estimation of HSV-2 in HIV high risk South-African women determined by two IgG ELISA methods. PLoS One. 2015 Mar 23;10(3):e0120207. https://doi.org/10.1371/journal.pone.0120207.
Parker C, Corneli A, Agot K, Odhiambo J, Asewe J, Ahmed K, Skhosana J, Ratlhagana M, Lanham M, Wong C, Deese J, Manongi R, Van Damme L. Lessons learned from implementing an empirically-informed recruitment approach for FEM-PrEP, a large HIV prevention clinical trial. Open Access Journal of Clinical Trials. 2015;7: 1-9. https://doi.org/10.2147/OAJCT.S68229.
Mandala J, Nanda K, Wang M, De Baetselier I, Deese J, Lombaard J, Owino F, Malahleha M, Manongi R, Taylor D, Van Damme L for the FEM-PrEP Study Group. Liver and Renal Safety of Tenofovir Disoproxil Fumarate in Combination with Emtricitabine among African Women in a Pre-exposure Prophylaxis Trial. BMC Pharmacol Toxicol 2014, 15:77. https://doi.org/10.1186/2050-6511-15-77.
Corneli A, Deese J, Wang M, Taylor D, Ahmed K, Agot K, Lombaard J, Manongi R, Kapiga S, Kashuba A, Van Damme L, for the FEM-PrEP Study Group. FEM-PrEP: Adherence patterns and factors associated with adherence to a daily, oral study product for pre-exposure prophylaxis. J Acquir Immune Defic Syndr. 2014; 66(3): 324-331. https://doi.org/10.1097/QAI.0000000000000158.
Todd K, Deese J, Wang M, Steiner M, Taylor D. Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya. Contraception. 2015 Mar;91(3):248-52. https://doi.org/10.1016/j.contraception.2014.10.008.
Grant R, Liegler T, Defechereux P, Kashuba A, Taylor D, Abedel-Mohsen M, Deese J, Fransen K, deBaetselier I, Crucitti T, Bentley G, Agingu W, Ahmed K, Lombaard J, Van Damme L. Drug resistance and plasma viral RNA level after suboptimal use of oral pre-exposure prophylaxis in women. AIDS. 2015 Jan 28;29(3):331-7. https://doi.org/10.1097/QAD.0000000000000556.
Guedou F, Van Damme L, Deese J, Crucitti T, Mirembe F, Solomon S, Becker M, Alary M. Intermediate vaginal flora and bacterial vaginosis are associated with the same factors: findings from an exploratory analysis among female sex workers in Africa and India. Sex Transm Infect 2014; 90: 161–164. https://doi.org/10.1136/sextrans-2012-050896.
Guedou F, Van Damme L, Deese J, Crucitti T, Becker M, Mirembe F, Solomon S, Alary M.S. Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial. BMC Infect Dis 2013; 13 (208): 1-11. https://doi.org/10.1186/1471-2334-13-208.
Ahmed K, Malahleha M, Deese J, Monedi C, Van Damme L. Elevated liver transaminases, human immune deficiency virus (HIV) seroconversion and rapid progression to AIDS in a HIV prevention clinical trial participant: A case report. Journal of AIDS and HIV Research 2013; 5 (3): 65-69. https://doi.org/10.5897/JAHR12.086.
Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, Owino F, Manongi, R, Onyango J, Temu L, Monedi MC, Mak'Oketch P, Makanda M, Reblin I, Makatu SE, Saylor, L, Kiernan H, Kirkendale S, Wong C, Grant R, Kashuba A, Nanda K, Mandala J, Fransen K, Deese J, Crucitti T, Mastro TD, Taylor D. Preexposure Prophylaxis for HIV Infection among African Women. N Engl J Med 2012; 367 (5): 411-22. https://doi.org/10.1056/NEJMoa1202614.
Guedou F, Becker M, Deese J, Mirembe F, Soloman S, Crucitti T, Van Damme L, Alary M. Intermediate vaginal flora is associated with HIV prevalence as strongly as bacterial vaginosis in a cross-sectional study of participants screened for a randomized controlled trial. Sex Transm Infect. 2014 Mar;90(2):161-4. https://doi.org/10.1136/sextrans-2011-050319.
Van Damme L, Govinden R, Mirembe F, Guédou F, Solomon S, Becker M, Pradeep B.S., Krishnan A. K. Alary M, Pandey B, Ramjee G, Deese J, Crucitti T, Taylor D. Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission. N Engl J Med 2008; 359 (5): 463-472. https://doi.org/10.1056/NEJMoa0707957.
Feldblum P, Caraway J, Bahamondes L, El-Shafei M, Ha D, Morales E, Wevill S, Condon S. Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: feasibility of enrollment, continuation and disease ascertainment. Contraception 2005; 72:187-191. https://doi.org/10.1016/j.contraception.2005.03.006.